NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Wyss Zurich

Wyss Zurich

Overview

Wyss Zurich is a joint accelerator of the University of Zurich and ETH Zurich that fosters translational research and invests in the fields of regenerative medicine, robotics, and medical devices/bionics technologies.

Year Founded

2015

Portfolio Companies

6

Investments

Wyss Zurich investments
CompanyDateStageLead
VeltistMay 2025AcceleratorCo-investor
MUVON TherapeuticsMay 2021Series ACo-investor
MUVON TherapeuticsApr 2021AcceleratorLead
OxyPremAug 2019AcceleratorCo-investor
Hemotune AGMay 2017GrantCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersZurich
Year Founded2015

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.